John Crowley

2020

In 2020, John Crowley earned a total compensation of $1.6M as Chief Financial Officer at Fusion Pharmaceuticals, a 88% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$196,597
Option Awards$951,608
Salary$437,795
Other$12,040
Total$1,598,040

Crowley received $951.6K in option awards, accounting for 60% of the total pay in 2020.

Crowley also received $196.6K in non-equity incentive plan, $437.8K in salary and $12K in other compensation.

Rankings

In 2020, John Crowley's compensation ranked 6,559th out of 13,090 executives tracked by ExecPay. In other words, Crowley earned more than 49.9% of executives.

ClassificationRankingPercentile
All
6,559
out of 13,090
50th
Division
Manufacturing
2,713
out of 5,618
52nd
Major group
Chemicals And Allied Products
1,093
out of 2,251
51st
Industry group
Drugs
947
out of 1,951
52nd
Industry
Biological Products, Except Diagnostic Substances
226
out of 411
45th
Source: SEC filing on April 27, 2021.

Crowley's colleagues

We found three more compensation records of executives who worked with John Crowley at Fusion Pharmaceuticals in 2020.

2020

John Valliant

Fusion Pharmaceuticals

Chief Executive Officer

2020

James O'Leary

Fusion Pharmaceuticals

Chief Medical Officer

2020

Eric Burak

Fusion Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like